Buprenorphine Prescriber Training

APA offers a number of training approaches for medication assisted treatment.

The 8-hour training activities below meet the Federal training requirement of the Drug Addiction Treatment Act of 2000 (DATA 2000). Completion will allow qualified physicians to apply for a waiver to their Drug Enforcement Administration (DEA) license, and thus to provide office-based treatment of opioid use disorder with buprenorphine. Physicians wishing to become waiver eligible can complete any one of the activities below.

Educational Offerings

Learning Method    
Book-based Learning – Office-Based Buprenorphine Treatment of Opioid Use Disorder, Second Edition
Purchase Claim Credit
In-Depth Online Training via APA Learning Center
Purchase Claim Credit

Instructions for Applying for a Buprenorphine Waiver

Once you have completed one of the above trainings and claimed your CME credit, APA will report your completion to SAMHSA. To claim your Buprenorphine Waiver, you must go to SAMHSA's "Buprenorphine Waiver Notification" website no sooner than 15 days from now. APA sends SAMHSA notifications of waiver training completion biweekly, and your information will be included in our next transmission.

Office-Based Buprenorphine Treatment of Opioid Use Disorder (Online + Live Discussion Panel)

APA, in collaboration with the American Academy of Addiction Psychiatry (AAAP), offers CME-accredited X-license waiver trainings for those seeking Medication-Assisted Treatment (MAT) / Buprenorphine-related CME through the Providers Clinical Support System (PCSS). This training offers our signature online waiver training course paired with a live discussion panel led by field experts for a more interactive learning experience. The course is available from Monday, April 5, 2021, to Friday, April 23, 2021.

Register Now

Medication-Assisted Treatment (MAT) Booster Activity

Using a question-based format, participants receive one multiple-choice question, by email, every other day. The activity consists of 25 questions over 60 days. Questions address the diagnosis, treatment, and longitudinal care of patients with Opioid Use Disorders.

View More

Model Curriculum in Substance Use Disorders

The National Institute on Drug Abuse (NIDA) and APA have developed educational activities that enable learners to manage psychoactive substance intoxication associated withdrawal and evidence-based psychotherapy and psychosocial interventions that include cognitive behavioral therapy and motivational interviewing.

View More